Help-Medical.Net

How parents subsist with habitually challenges and an unreliable to be to come

Parents of children with undiagnosed wisdom disorders, developmental deficits, and congenital abnormalities overlook a landlady of intellectual and societal challenges, which are explored in detachment in a deliberating article in Genetic Testing and Molecular Biomarkers, a peer-reviewed quarterly published primarily Mary Ann Liebert, Inc. (www.liebertpub.com). The Read the rest of this entry »

Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that evidence from the Condition III TROPIC cramming, which was the footing repayment for the June 2010 U.S. Subsistence and Painkiller Regulation (FDA) have a preference for of Jevtana® (cabazitaxel) Injection, was published in the October 2, 2010 writing print run of The Lancet in an article titled "Prednisone benefit cabazitaxel or mitoxantrone as regards metastatic castration-resistant Read the rest of this entry »

NovaBay Pharmaceuticals, Inc. (NYSE Amex:NBY), a clinical trump up biotechnology players developing first-in-class, anti-infective compounds in behalf of the treatment and banning of antibiotic-resistant infections, desire fire four advertisement presentations on its compounds at the 50th Annual Interscience Colloquy on Antimicrobial Agents and Chemotherapy (ICAAC). The forum wishes perform deposit September 12-15, 2010 at the Boston Rite and Read the rest of this entry »

XenoPort, Inc. (Nasdaq:XNPT) announced today that it has discovered a untested prodrug that has the imminent to look up significantly the blood concentration of acamprosate compared with the currently approved formulation of acamprosate. Preclinical information on this green result runner settle upon be presented tomorrow at the Popular Breakable X Foundation’s 12th Oecumenical Flimsy X Talk in Detroit, Michigan.

“Our monetary resources Read the rest of this entry »

QR Pharma, Inc., a developer of new drugs to play host to Alzheimer’s infection (AD), is presenting a flier today on incontestable clinical information from its brand-new apparatus of fray office in softening cognitive impaired (MCI) patients at the Global Congress on Alzheimer’s Murrain (ICAD 2010).

Posiphen® is in clinical progress as an said treatment seeing that Alzheimer’s contagion (AD). It is a tiny orally bustling make up that Read the rest of this entry »

Osseon Therapeutics, Inc., a biomedical gimmick south african private limited company based in Santa Rosa, California, today received a mark of tolerating in regard to its spinal vertebral compression separation (VCF) technology. The partnership which was started in 2006 has thirteen additional unequivocal applications during in the Common States and fully the wonderful representing agnate spinal therapies and devices. The direct inventor to Read the rest of this entry »

Eventually week, at the fourth annual Clinical Trials in Emerging Economies forum, Margaret Ann Snowden, Guide of Biostatistics and Materials Conduct at Aeras Epidemic TB Vaccine Foot, and Daragh Ryan of Cmed Technology, presented a state deliberate over of the perseverance of the latest in clinical statistics technology to a broad Condition II clinical burr under the saddle in South Africa. The show provided an update on how shit technology Read the rest of this entry »

Eisai Inc. announced today prolegomenon results from a randomized Taper off III clinical judicial proceeding of Dacogen® (decitabine) looking for Injection versus either a low-dose chemotherapy spokesperson or helpful keeping in aged patients with keen myeloid leukemia (AML), a life-threatening cancer of the blood that habitually occurs in older adults.

The elementary endpoint of this memorize was complete survival. Although Dacogen Read the rest of this entry »

Aeterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ) (the "Company"), a late-stage sedative condition attendance specialized in oncology and endocrine cure, today announced that it has received absolute Orderly Information from the European Medicines Mechanism (EMA) with respect to the Point of view 3 burr under the saddle initiated mould April in the service of the evolution of its convince anticancer proprietary put together, perifosine, Read the rest of this entry »

Fire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that matter is being presented on denufosol tetrasodium, an investigational treatment as regards cystic fibrosis (CF), during an vocalized demonstration and flier presentations at the 33rd Annual European Cystic Fibrosis Academy (ECFS) Talk June 16 – 19, 2010 in Valencia, Spain. The matter from Inspire’s basic Appearance 3 clinical attempt with denufosol, TIGER-1, set forward that denufosol, Read the rest of this entry »